循证医学在临床医生的需求
Evidence-based medicine (EBM), which integrates clinical expertise and the best available evidence, has been used in academic settings for decades. Now, as a result of a collaboration between theAgency for Healthcare Research and Quality(AHRQ) andEpocrates, Inc., a developer of clinical solutions, all healthcare professionals can access this valuable information.
"A physician's experience and direct knowledge about each patient will always play a central role in delivering care," said AHRQ Director Carolyn M. Clancy, M.D.
"By connecting with Epocrates' extensive network and delivering EBM findings, we are helping to further augment the physician's expertise with the collective experience of thousands of patient cases and studies over many years."
AHRQ advocates the translation of evidence-based research findings to drive quality improvements throughout the healthcare delivery system.
AHRQ synthesizes emerging evidence and distills research findings into practical recommendations for effective care. Epocrates provides the resulting evidence- based practices as electronic alerts to its network of more than 500,000 clinicians via mobile devices.
Recent AHRQ messages include EBM recommendations about which patients should be screened for iron-deficiency anemia, hemochromatosis, speech delay, breast cancer genes and aneurysms.
Additional topics include emerging evidence on reducing heart attack and death with anti-clotting drugs in patients with cardiac stents, and an exploration of the role of genetic tests in guiding depression treatment.
"Our products are designed to provide answers at the point of care and support the best in patient care. By working with the AHRQ, we are providing additional information to aid clinicians in their decision making process," said Kirk Loevner, chairman and chief executive officer of Epocrates.
"Today's physicians are able to provide higher quality care by referencing an abundance of resources and research available at their fingertips," Loevnera added.
